(Q40787828)

23 September 2017

title

Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation (English)

1 reference

23 September 2017

1 reference

Alt M

1

1 reference

23 September 2017

Eisenhardt S

2

1 reference

23 September 2017

Serwe M

3

1 reference

23 September 2017

Renz R

4

1 reference

23 September 2017

Engels JW

5

1 reference

23 September 2017

Caselmann WH

6

1 reference

23 September 2017

publication date

1 October 1999

1 reference

European Journal of Clinical Investigation

23 September 2017

published in

1 reference

23 September 2017

volume

29

1 reference

23 September 2017

issue

10

1 reference

23 September 2017

page(s)

868-876

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Application of antisense technology to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

The therapeutic potential of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antisense oligonucleotides: towards clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Progress in antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Pharmacokinetics of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antisense oligonucleotides as antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Specificity of antisense oligonucleotides in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00552.X

10.1046/J.1365-2362.1999.00552.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference